Global WholeHealth Partners Corporation (GWHP)
USD 0.0
(-90.0%)
USD 0.0
(-90.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 692.13 Thousand USD | 1127.12% |
| 2021 | 56.4 Thousand USD | -68.01% |
| 2020 | 176.31 Thousand USD | 985.22% |
| 2019 | -19.91 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2014 | 137.12 Thousand USD | 100.71% |
| 2013 | 68.31 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 FY | - USD | -100.0% |
| 2022 Q4 | 692.13 Thousand USD | -45.01% |
| 2022 FY | 692.13 Thousand USD | 1127.12% |
| 2022 Q3 | 1.25 Million USD | -5.02% |
| 2022 Q2 | 1.32 Million USD | 1364.88% |
| 2022 Q1 | -104.76 Thousand USD | -285.75% |
| 2021 Q3 | 253.4 Thousand USD | 66.76% |
| 2021 Q1 | 53.33 Thousand USD | -69.75% |
| 2021 Q4 | 56.4 Thousand USD | -77.74% |
| 2021 Q2 | 151.95 Thousand USD | 184.93% |
| 2021 FY | 56.4 Thousand USD | -68.01% |
| 2020 Q3 | 62.2 Thousand USD | 64230.93% |
| 2020 FY | 176.31 Thousand USD | 985.22% |
| 2020 Q1 | -120.00 USD | 99.4% |
| 2020 Q2 | -97.00 USD | 19.17% |
| 2020 Q4 | 176.31 Thousand USD | 183.44% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | -19.91 Thousand USD | 0.0% |
| 2019 FY | -19.91 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2015 Q1 | 135.68 Thousand USD | -1.05% |
| 2015 Q2 | 136.21 Thousand USD | 0.39% |
| 2015 Q3 | -15.00 USD | -100.01% |
| 2014 Q1 | 113.56 Thousand USD | 0.0% |
| 2014 Q2 | 114.62 Thousand USD | 0.93% |
| 2014 Q3 | 115.11 Thousand USD | 0.43% |
| 2014 Q4 | 137.12 Thousand USD | 19.12% |
| 2014 FY | 137.12 Thousand USD | 100.71% |
| 2013 FY | 68.31 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 100.0% |
| Arrayit Corporation | 1.05 Million USD | 100.0% |
| Atlantic International Corp. | 236.49 Thousand USD | 100.0% |
| Biocept, Inc. | -788 Thousand USD | 100.0% |
| Bioqual, Inc. | -12 Million USD | 100.0% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 100.0% |
| DermTech, Inc. | 17.65 Million USD | 100.0% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 100.0% |
| iMD Companies, Inc. | 1.11 Million USD | 100.0% |
| IDenta Corp. | 524.85 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 100.0% |
| InVitro International | -313.14 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 100.0% |
| Medical Imaging Corp. | 3.79 Million USD | 100.0% |
| NovelStem International Corp. | 3.52 Million USD | 100.0% |
| Optigenex Inc. | 8.93 Million USD | 100.0% |
| PharmChem, Inc. | -1.49 Million USD | 100.0% |
| Proteome Sciences plc | 14.57 Million USD | 100.0% |
| Response Genetics, Inc | -13.08 Million USD | 100.0% |
| Rennova Health, Inc. | 14.82 Million USD | 100.0% |
| RushNet, Inc. | 4.8 Million USD | 100.0% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 100.0% |
| Stella Diagnostics Inc. | 6.19 Million USD | 100.0% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 100.0% |
| Todos Medical Ltd. | 38.31 Million USD | 100.0% |